Dr. Reddy's Laboratories Limited
NSE: DRREDDY BSE: DRREDDY
Prev Close
1116.5
Open Price
1118.35
Volume
663,796
Today Low / High
1108.25 / 1130.25
52 WK Low / High
1104.55 / 1421.49
Range
1,053 - 1,164
Upper Circuit (5%)
1,163.66
Lower Circuit (5%)
1,052.84
Prev Close
1117.65
Open Price
1117.65
Volume
18,980
Today Low / High
1108 / 1130
52 WK Low / High
1105 / 1420.2
Range
1,055 - 1,166
Upper Circuit (5%)
1,166.03
Lower Circuit (5%)
1,054.98
The stock performance of Dr. Reddy's Laboratories Limited on both the NSE and BSE. On the NSE, the stock is priced at ₹1108.25 (target range: ₹1,053 - ₹1,164), reflecting a slight increase of -0.74%, with a trading volume of 663,796 shares. On the BSE, the stock is trading at ₹1110.5 (target range: ₹1,055 - ₹1,166), up by -0.64% with a volume of 18,980 shares. Both exchanges show similar low and high prices, with NSE at ₹1108.25 - ₹1130.25 and BSE at ₹1108 - ₹1130 The 52-week range stands at ₹1421.49 - ₹1104.55 on both exchanges. The stock is declining on both exchanges, indicating a downtrend. Monitor closely before making investment decisions.
Dr. Reddy's Laboratories Limited Chart
Comprehensive Overview of Dr. Reddy's Laboratories Limited
ISIN
INE089A01023
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
2,450,882
Market Cap
923,868,485,079
Last Dividend
8
Range
1104.55-1421.49
Official Website
IPO Date
1996-01-01
DCF Diff
-4,195.44
DCF
10,710
Latest Dividend Details of Dr. Reddy's Laboratories Limited
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-07-16 | July 16, 24 | 8 | 40 | 2024-07-16 | 2024-08-28 | |
| 2023-07-11 | July 11, 23 | 40 | 200 | 2023-07-11 | 2023-08-26 | |
| 2022-07-11 | July 11, 22 | 30 | 150 | 2022-07-12 | 2022-08-28 | |
| 2021-07-09 | July 09, 21 | 5 | 25 | 2021-07-12 | 2021-08-27 | |
| 2020-07-13 | July 13, 20 | 5 | 25 | 2020-07-14 | 2020-08-29 | 2020-05-20 |
Comprehensive Annual Financial Performance Report of Dr. Reddy's Laboratories Limited
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 27,916.40 Cr | 11,555.70 Cr | 16,360.70 Cr | 0.5861 | 2,287.30 Cr | 0.00 Cr | 6,772.90 Cr | 5,568.40 Cr | 334.41 | 8,827.50 Cr | 0.1995 |
| 2023-03-31 | 24,587.90 Cr | 7,657.70 Cr | 16,930.20 Cr | 0.6886 | 1,938.10 Cr | 4,646.60 Cr | 5,714.40 Cr | 4,506.70 Cr | 271.43 | 7,406.10 Cr | 0.1833 |
| 2022-03-31 | 21,439.10 Cr | 10,055.10 Cr | 11,384.00 Cr | 0.5310 | 1,748.20 Cr | 0.00 Cr | 2,947.60 Cr | 2,356.80 Cr | 142.08 | 4,774.30 Cr | 0.1099 |
| 2021-03-31 | 18,972.20 Cr | 8,664.50 Cr | 10,307.70 Cr | 0.5433 | 1,654.10 Cr | 0.00 Cr | 2,619.10 Cr | 1,723.80 Cr | 103.94 | 4,570.60 Cr | 0.0909 |
| 2020-03-31 | 17,460.00 Cr | 8,059.10 Cr | 9,400.90 Cr | 0.5384 | 1,541.00 Cr | 0.00 Cr | 1,599.30 Cr | 1,949.80 Cr | 117.63 | 4,178.50 Cr | 0.1117 |
Essential Financial Ratios Every Investor Must Know of Dr. Reddy's Laboratories Limited
Comprehensive Annual Balance Sheet Overview of Dr. Reddy's Laboratories Limited
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 710.70 Cr | 38,751.80 Cr | 10,696.80 Cr | 28,055.0000 Cr | 2,002.00 Cr | 1,291.30 Cr | 6,355.20 Cr | 7,688.60 Cr | 143.50 Cr | 119.30 Cr | 525.50 Cr | 9,603.9000 Cr |
| 2023-03-31 | 577.90 Cr | 32,285.10 Cr | 8,999.00 Cr | 23,286.1000 Cr | 1,347.20 Cr | 769.30 Cr | 4,867.00 Cr | 5,654.20 Cr | 198.10 Cr | 155.50 Cr | 608.90 Cr | 8,572.1000 Cr |
| 2022-03-31 | 1,485.20 Cr | 29,665.40 Cr | 10,612.70 Cr | 19,052.7000 Cr | 3,384.50 Cr | 1,899.30 Cr | 5,088.40 Cr | 6,216.90 Cr | 257.60 Cr | 159.70 Cr | 798.60 Cr | 9,784.2000 Cr |
| 2021-03-31 | 1,482.90 Cr | 26,549.10 Cr | 9,051.00 Cr | 17,498.1000 Cr | 3,030.80 Cr | 1,547.90 Cr | 4,541.20 Cr | 5,711.10 Cr | 203.30 Cr | 153.10 Cr | 833.30 Cr | 8,147.2000 Cr |
| 2020-03-31 | 205.30 Cr | 23,224.10 Cr | 7,725.30 Cr | 15,498.8000 Cr | 2,210.20 Cr | 2,004.90 Cr | 3,506.60 Cr | 5,233.20 Cr | 191.00 Cr | 195.60 Cr | 309.10 Cr | 7,281.4000 Cr |
Annual Financial Cash Flow Statement Overview of Dr. Reddy's Laboratories Limited
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 4,543.3000 Cr | -4,028.3000 Cr | -376.3000 Cr | 1,799.8000 Cr | 132.8000 Cr | 710.7000 Cr | -2,743.5000 Cr | 5,568.4000 Cr | 434.6000 Cr | -664.8000 Cr | -1,844.5000 Cr |
| 2023-03-31 | 5,887.3000 Cr | -4,137.1000 Cr | -2,686.1000 Cr | 4,000.9000 Cr | -907.3000 Cr | 577.9000 Cr | -1,886.4000 Cr | 6,048.5000 Cr | -1,938.2000 Cr | -497.9000 Cr | -265.4000 Cr |
| 2022-03-31 | 2,810.8000 Cr | -2,638.7000 Cr | -242.2000 Cr | 905.9000 Cr | 3.2000 Cr | 1,485.2000 Cr | -1,904.9000 Cr | 2,356.8000 Cr | 273.5000 Cr | -414.6000 Cr | -532.8000 Cr |
| 2021-03-31 | 3,570.3000 Cr | -2,266.0000 Cr | -29.8000 Cr | 2,314.2000 Cr | 1,285.8000 Cr | 1,482.0000 Cr | -1,256.1000 Cr | 1,914.9000 Cr | -69.7000 Cr | -414.7000 Cr | -988.1000 Cr |
| 2020-03-31 | 2,984.1000 Cr | -492.3000 Cr | -2,515.9000 Cr | 2,372.6000 Cr | -26.6000 Cr | 196.2000 Cr | -611.5000 Cr | 1,949.8000 Cr | -2,340.0000 Cr | -391.6000 Cr | -148.7000 Cr |
Quarterly Financial Performance Highlights of Dr. Reddy's Laboratories Limited
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 8,358.60 Cr | 3,453.40 Cr | 4,905.20 Cr | 0.5868 | 1,872.00 Cr | 1,413.30 Cr | 16.96 | 2,427.90 Cr | 0.1691 |
| 2024-09-30 | 8,016.20 Cr | 3,458.10 Cr | 4,558.10 Cr | 0.5686 | 1,755.10 Cr | 1,255.30 Cr | 15.04 | 2,383.80 Cr | 0.1566 |
| 2024-06-30 | 7,672.70 Cr | 3,250.10 Cr | 4,422.60 Cr | 0.5764 | 1,754.20 Cr | 1,392.00 Cr | 83.58 | 2,175.70 Cr | 0.1814 |
| 2024-03-31 | 7,083.00 Cr | 2,934.70 Cr | 4,148.30 Cr | 0.5857 | 1,413.00 Cr | 1,307.00 Cr | 78.49 | 2,028.60 Cr | 0.1845 |
| 2023-12-31 | 7,214.80 Cr | 2,994.50 Cr | 4,220.30 Cr | 0.5850 | 1,726.70 Cr | 1,378.90 Cr | 82.81 | 2,161.80 Cr | 0.1911 |
Comprehensive Quarterly Financial Balance Sheet of Dr. Reddy's Laboratories Limited
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1,228.90 Cr | 4,689.00 Cr | 5,917.90 Cr | 11,149.40 Cr | 7,163.00 Cr | 25,301.60 Cr | 9,305.30 Cr | 48,105.90 Cr | 15,949.40 Cr |
| 2024-09-30 | 1,133.00 Cr | 5,174.40 Cr | 6,307.40 Cr | 9,190.30 Cr | 7,203.90 Cr | 24,812.80 Cr | 8,669.30 Cr | 46,595.50 Cr | 15,667.20 Cr |
| 2024-06-30 | 491.30 Cr | 8,971.30 Cr | 9,462.60 Cr | 8,108.80 Cr | 6,856.80 Cr | 26,918.80 Cr | 8,034.30 Cr | 41,529.70 Cr | 12,067.00 Cr |
| 2024-03-31 | 710.70 Cr | 7,436.30 Cr | 8,147.00 Cr | 8,029.80 Cr | 6,355.20 Cr | 24,804.90 Cr | 7,688.60 Cr | 38,751.80 Cr | 10,696.80 Cr |
| 2023-12-31 | 734.20 Cr | 6,501.50 Cr | 7,235.70 Cr | 8,473.70 Cr | 6,079.60 Cr | 23,847.70 Cr | 7,279.50 Cr | 37,284.20 Cr | 10,499.20 Cr |
Quarterly Cash Flow Statement: A Detailed Financial Overview of Dr. Reddy's Laboratories Limited
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1,403.80 Cr | 662.00 Cr | -545.80 Cr | 59.00 Cr | 174.70 Cr | 1,303.20 Cr | 1,128.50 Cr | -881.90 Cr | -219.90 Cr |
| 2024-09-30 | 1,255.30 Cr | 931.60 Cr | -1,284.90 Cr | 1,003.10 Cr | 637.20 Cr | 1,128.50 Cr | 491.30 Cr | -790.90 Cr | 140.70 Cr |
| 2024-06-30 | 1,392.00 Cr | 819.80 Cr | -2,069.40 Cr | 1,028.50 Cr | -219.40 Cr | 491.30 Cr | 710.70 Cr | -642.40 Cr | 177.40 Cr |
| 2024-03-31 | 1,307.00 Cr | 1,129.00 Cr | -1,177.80 Cr | 14.00 Cr | -42.80 Cr | 710.70 Cr | 753.50 Cr | -628.30 Cr | 500.70 Cr |
| 2023-12-31 | 1,378.90 Cr | 473.70 Cr | -1,618.00 Cr | 528.20 Cr | -600.00 Cr | 753.50 Cr | 1,353.50 Cr | -504.20 Cr | -30.50 Cr |
Historical Stock Splits Overview of Dr. Reddy's Laboratories Limited
| Date | Label | Split Ratio |
|---|---|---|
| 2024-10-28 | October 28, 24 | 5:1 |
| 2006-08-28 | August 28, 06 | 2:1 |
| 2001-10-10 | October 10, 01 | 2:1 |
Executive Profiles of Dr. Reddy's Laboratories Limited
Gender: male
Year Born: 1975
Gender: male
Year Born: 1968
Gender: male
Year Born: 1960
Gender: male
Year Born: 1969
Gender: female
Year Born: 1967
Gender: male
Year Born: 1965
Gender: male
Year Born: 1967
Gender: male
Year Born:
Gender: male
Year Born: 1973
Gender: male
Year Born: 1968
Frequently Asked Questions about Dr. Reddy's Laboratories Limited
The CEO of the company is Mr. Erez Israeli M.B.A..
The current trading price of the stock is ₹1,108.95.
The 52-week price range of this stock is ₹1104.55-1421.49.
The market capitalization of the company is ₹92,386.85 crores.
The dividend yield represents the percentage of a company stock price paid out as dividends annually. For example, if the dividend yield is 0.72%, it means the company pays this percentage of its stock price as a dividend each year.
The P/E ratio is a measure of a company stock price relative to its earnings per share (EPS). For this stock, the current P/E ratio is 17.22.
The company operates in the Healthcare sector.
The current price of Dr. Reddy's Laboratories Limited is ₹1,108.95. If the stock takes a bullish turn, you can expect the target price to be around ₹1,164.40. On the other hand, if the market turns bearish, the target price could drop to approximately ₹1,053.50.
The company, Dr. Reddy's Laboratories Limited (ISIN: INE089A01023), is a leading player in the Drug Manufacturers - Specialty & Generic sector in India. With a market capitalization of ₹92,386.85 crores and an average daily trading volume of 2,450,882 shares, it is actively engaged in the Drug Manufacturers - Specialty & Generic industry. The company recently declared a dividend of 8."